Abstract

Hyponatremia on admission has been related to worse outcomes in patients with COVID-19 infection. However, little is known about the frequency and the associated risk factors of hyponatremia after COVID-19 discharge. We performed an observational 24-month follow-up study of patients admitted during the first COVID-19 wave. Kaplan–Meier curves and Cox proportional hazard models were used to assess the main variables in predicting hyponatremia on follow-up (HYPO-FU). A total of 161 out of 683 (24.4%) developed HYPO-FU. The group with HYPO-FU comprised of more men [(62.3%) vs. (49.2%); p < 0.01], older [65.6 ± 18.2 vs. 60.3 ± 17.0; p < 0.01] and more frequently re-admitted [(16.2%) vs. (3.8%); p < 0.01). The rate of HYPO-FU was higher in the first year 23.6 per 100 individuals per year. After Cox regression analysis, the independent risk factors of HYPO-FU were diabetes [OR 2.12, IC 95% (1.48–3.04)], hypertension [OR 2.18, IC 95% (1.53–3.12)], heart failure [OR 3.34, IC 95% (1.72–6.48)] and invasive ventilation support requirement [OR: 2.38, IC 95% (1.63–3.50)]. To conclude, HYPO-FU was frequent in the first year after COVID-19 infection, and the risk was higher in older men with comorbidities, increasing rehospitalisation. Further studies aimed at evaluating the beneficial effects of correcting hyponatremia in these patients are warranted.

Details

Title
Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions
Author
Biagetti, Betina 1   VIAFID ORCID Logo  ; Sánchez-Montalvá, Adrián 2 ; Puig-Perez, Albert 1 ; Campos-Varela, Isabel 3 ; Pilia, María Florencia 4 ; Anderssen-Nordahl, Emilie 5 ; González-Sans, Didac 6 ; Miarons, Marta 7 ; Simó, Rafael 1   VIAFID ORCID Logo 

 Universidad Autónoma de Barcelona, Endocrinology Department, Diabetes and Metabolism Research Unit, Vall d’Hebron University Hospital and Vall d’Hebron Research Institute (VHIR), Barcelona, Spain (GRID:grid.7080.f) (ISNI:0000 0001 2296 0625) 
 Universitat Autònoma de Barcelona, Infectious Diseases Department, Vall d’Hebrón University Hospital, Global Health Program from the Catalan Health Institute (PROSICS), Barcelona, Spain (GRID:grid.7080.f) (ISNI:0000 0001 2296 0625); Mycobacterial Infection Study Group from the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIM-SEIMC), Barcelona, Spain (GRID:grid.7080.f); Instituto de Salud Carlos III, Infectious Diseases Netword Biomedical Research Center (CIBERINFEC), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
 Vall d’Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Liver Unit, Vall d’Hebron Hospital Universitari, Vall d’Hebron Institut of Research (VHIR), Barcelona, Spain (GRID:grid.7080.f) (ISNI:0000 0001 2296 0625); Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
 Autonomous University of Barcelona (UAB), Pneumology Department, Vall d’Hebron University Hospital, Department of Medicine, Barcelona, Spain (GRID:grid.7080.f) (ISNI:0000 0001 2296 0625); Vall d’Hebron Research Institute (VHIR), Barcelona, Spain (GRID:grid.430994.3) (ISNI:0000 0004 1763 0287) 
 Vall d’Hebron University Hospital, Vall d’Hebron Barcelona Hospital Campus, Department of Clinical Pharmacology, Barcelona, Spain (GRID:grid.411083.f) (ISNI:0000 0001 0675 8654) 
 Vall d’Hebron Barcelona Hospital Campus, Systemic Autoimmune Diseases Unit, Internal Medicine Department, Hospital Universitario Vall d’Hebron, Barcelona, Spain (GRID:grid.411083.f) (ISNI:0000 0001 0675 8654) 
 Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Pharmacy Department, Barcelona, Spain (GRID:grid.411083.f) (ISNI:0000 0001 0675 8654) 
Pages
595
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2910735487
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.